Countries Australia
Australia Achieves Positive Results in Phase Ib Study for Androgenic Alopecia Treatment
This study is led by Professor Rodney Sinclair and included 12 male and 4 female patients in Australia with androgenic alopecia (AGA). ...
January 15, 2024 | News
GC Cell Initiates Phase 1 Trials for AB-201 Cancer Treatment with Lunit AI Platform
GC Cell, a fully integrated cell therapy pioneer, is proud to announce the approval from both the Australian Human Research Ethics Committee (HREC) a...
January 09, 2024 | News
Australia's GPN Vaccines Reports Positive Phase 1 Data for Gamma-PN Trial
In this double-blind, randomised study with placebo and active controls, 120 participants received either two doses of 50, 250 or 1000 micrograms of Gamma-...
January 04, 2024 | News
Asieris' APL-2301 Approved for Phase I Trials in Australia for Acinetobacter baumannii Infection
The planned clinical trial in Australia will be the first-in-human Phase I trial for APL-2301. It aims to evaluate the safety, tolerability, phar...
December 26, 2023 | News
Biocon Biologics Successfully Integrates Acquired Biosimilars Business Across 120 Countries
Biocon Biologics, a unique, fully integrated, global biosimilars company with a rich portfolio of insulins and monoclonal antibodies, has successfully conc...
December 19, 2023 | News
Australian Neuren Phase 2 Trial Reveals Significant Improvements in Phelan-McDermid Syndrome
Highlights: Significant improvement was assessed by both clinicians and caregivers across multiple efficacy measures Improvements were con...
December 19, 2023 | News
Advancing Lung Cancer Treatment: Insights from Professor Benjamin Solomon on the ALINA Study and the Future of ALK-Positive NSCLC
In an exclusive BioPharma APAC interview, Professor Benjamin Solomon, a distinguished Medical Oncologist at the Peter MacCallum Cancer Centre, Australia, a...
December 18, 2023 | News
MGI Australia Introduces Innovative CEC with DCS Lab Products for Advanced DNA, Cell, and Spatial-omics Technology
MGI Australia, a subsidiary of MGI Tech Co. Ltd. (MGI), a global leader in life science technology, is delighted to announce a substantial expans...
December 15, 2023 | News
Atmo Biosciences achieves patient recruitment target for dysmotility pivotal clinical study
Atmo Biosciences, a company commercializing the world’s first ingestible gas-sensing capsule that provides insights into gut health and microbiome fu...
December 14, 2023 | News
Imagion Reports Positive Results in Phase I Study for MagSense® HER2 Imaging Agent
Imagion Biosystems Limited (ASX: IBX) recently announced positive results following completion of the IBI10103 phase I clinical trial evaluating the safety...
December 14, 2023 | News
Clover Initiates Phase Ⅰ Clinical Trial for RSV Vaccine Candidate
Clover Biopharmaceuticals, Ltd. a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save li...
December 13, 2023 | News
First Patient Dosed in U.S. Access Program for Telix's TLX250-CDx Kidney Cancer Imaging
The patient was dosed at ARA Diagnostic Imaging at Austin Radiological Association in Austin (TX, U.S.) following U.S. Food and Drug Administrati...
December 12, 2023 | News
Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced its progression to the second st...
December 12, 2023 | News
IonOpticks and Newomics Collaborate to Boost Aurora Series Columns Compatibility with Agilent Mass Spectrometers
IonOpticks is renowned for its class-leading chromatography solutions, particularly the Aurora Series, which are celebrated for their precision, ef...
December 07, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
